Misonix Inc Receivables Turnover Ratio (MSON), from the fourth quarter 2021 to the fourth quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Misonix Inc   (NASDAQ: MSON)
 

Misonix Inc Accounts Receivables Turnover Ratio from the fourth quarter 2021 to the fourth quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Misonix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2021 to a ratio of 6.41, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the fourth quarter 2021. Average receivable collection period, for the Misonix Inc in Jun 30 2021 quarter, has decreased to 57 days, compared to 62 days, in the Mar 31 2021 quarter.

If we take a look into Healthcare sector 339 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2021 from 2229 to 2395.

What is Receivable Turnover Ratio?
What is Misonix Inc Selling?


What is Receivable Turnover Ratio?





MSON Receivables Turnover Ratio (Jun 30 2021)
IV. Quarter
(Mar 31 2021)
III. Quarter
(Dec 31 2020)
II. Quarter
(Sep 30 2020)
I. Quarter
(Jun 30 2020)
IV. Quarter
Y / Y Receivable Change 2.58 % -18.15 % -14.38 % -7.86 % 106.41 %
Y / Y Revenue Change 43.55 % 2.48 % -7.43 % 59.12 % 40.59 %
Receivable Turnover Ratio (TTM) 6.41 5.93 5.57 5.48 4.86
MSON's Total Ranking # 2395 # 2229 # 2234 # 2229 # 1957
Accounts Receivable average collection period days 57 62 66 67 75
Seq. Receivable Change -5.69 % 8.64 % -5.54 % 5.99 % -24.75 %
Seq. Revenue Change 7.29 % 0.5 % 2.94 % 29.33 % -23.4 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 340
Overall Market # 2395

Receivable Turnover Ratio Statistics
High Average Low
8.06 6.11 4.86
(Jun 30 2018)   (Jun 30 2020)






Financial Statements
Misonix Inc 's Accounts Receivable $ 11 Millions Visit MSON's Balance sheet
Misonix Inc 's Sales TTM $ 74 Millions Visit MSON's Income Statement
Sources of MSON's Revenues Visit MSON's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MSON's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MSON's Growth Rates MSON's Roa MSON's Inventory Turnover Ratio MSON's Dividend Comparisons
MSON's Profitability Ratios MSON's Roi MSON's Asset Turnover Ratio MSON's Dividend Growth
MSON's Valuation Ratios MSON's Roe MSON's Financial Strength Ratios MSON's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2021 Receivable at quarter ending Jun 30 2021
Dariohealth Corp   17.69 $ 11.360  Millions$ 0.642  Millions
Cormedix Inc   17.43 $ 0.245  Millions$ 0.014  Millions
Neurometrix Inc   17.27 $ 8.215  Millions$ 0.476  Millions
Electrocore Inc   16.68 $ 4.482  Millions$ 0.269  Millions
Scorpius Holdings inc   16.47 $ 2.451  Millions$ 0.149  Millions
Mannkind Corporation  16.35 $ 74.511  Millions$ 4.558  Millions
Protalix Biotherapeutics inc   15.91 $ 48.032  Millions$ 3.019  Millions
Catheter Precision Inc   15.46 $ 4.254  Millions$ 0.275  Millions
Longeveron Inc   15.05 $ 0.489  Millions$ 0.033  Millions
Rafael Holdings Inc  15.00 $ 3.971  Millions$ 0.265  Millions
Xencor Inc  14.79 $ 178.632  Millions$ 12.082  Millions
Chimerix Inc   14.74 $ 4.555  Millions$ 0.309  Millions
Travere Therapeutics Inc   14.61 $ 204.146  Millions$ 13.969  Millions
Avita Medical Inc   14.48 $ 29.232  Millions$ 2.019  Millions
Ultragenyx Pharmaceutical Inc   14.29 $ 359.382  Millions$ 25.152  Millions
Myomo Inc   14.26 $ 11.157  Millions$ 0.783  Millions
Patterson Companies Inc   14.19 $ 6,281.105  Millions$ 442.648  Millions
Corcept Therapeutics Inc  14.01 $ 343.087  Millions$ 24.494  Millions
Cytokinetics Incorporated  13.93 $ 57.801  Millions$ 4.150  Millions
Lexicon Pharmaceuticals Inc   13.92 $ 7.094  Millions$ 0.510  Millions
Beone Medicines Ltd   13.60 $ 947.044  Millions$ 69.617  Millions
International Stem Cell Corporation  13.60 $ 6.447  Millions$ 0.474  Millions
Alpha Pro Tech Ltd   13.29 $ 100.013  Millions$ 7.524  Millions
Lensar Inc   13.16 $ 30.394  Millions$ 2.310  Millions
Mymetics Corporation  13.05 $ 0.656  Millions$ 0.050  Millions
Semler Scientific inc   13.05 $ 50.294  Millions$ 3.853  Millions
Pulmatrix Inc   12.70 $ 10.016  Millions$ 0.789  Millions
Eargo Inc   12.63 $ 85.495  Millions$ 6.767  Millions
La Jolla Pharmaceutical Company  12.48 $ 70.219  Millions$ 5.628  Millions
Surmodics Inc   12.41 $ 103.708  Millions$ 8.359  Millions

Date modified: 2026-10-07T00:41:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.